vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and VINCE HOLDING CORP. (VNCE). Click either name above to swap in a different company.
VINCE HOLDING CORP. is the larger business by last-quarter revenue ($85.1M vs $47.7M, roughly 1.8× IRONWOOD PHARMACEUTICALS INC). VINCE HOLDING CORP. runs the higher net margin — 3.2% vs -4.8%, a 8.0% gap on every dollar of revenue. On growth, VINCE HOLDING CORP. posted the faster year-over-year revenue change (6.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-5.7M). Over the past eight quarters, VINCE HOLDING CORP.'s revenue compounded faster (6.3% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
VINCE. is a contemporary clothing fashion brand founded in 2002. In 2023 Authentic Brands Group purchased its intellectual property in a $76.5 million deal.
IRWD vs VNCE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $85.1M |
| Net Profit | $-2.3M | $2.7M |
| Gross Margin | — | 49.2% |
| Operating Margin | 14.3% | 6.4% |
| Net Margin | -4.8% | 3.2% |
| Revenue YoY | -47.3% | 6.2% |
| Net Profit YoY | -200.9% | -37.3% |
| EPS (diluted) | $0.01 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $85.1M | ||
| Q3 25 | $122.1M | $73.2M | ||
| Q2 25 | $85.2M | $57.9M | ||
| Q1 25 | $41.1M | $80.0M | ||
| Q4 24 | $90.5M | $80.2M | ||
| Q3 24 | $91.6M | $74.2M | ||
| Q2 24 | $94.4M | $59.2M | ||
| Q1 24 | $74.9M | $75.3M |
| Q4 25 | $-2.3M | $2.7M | ||
| Q3 25 | $40.1M | $12.1M | ||
| Q2 25 | $23.6M | $-4.8M | ||
| Q1 25 | $-37.4M | $-28.3M | ||
| Q4 24 | $2.3M | $4.3M | ||
| Q3 24 | $3.6M | $569.0K | ||
| Q2 24 | $-860.0K | $4.4M | ||
| Q1 24 | $-4.2M | $-4.7M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 50.4% | ||
| Q2 25 | — | 50.3% | ||
| Q1 25 | — | 50.1% | ||
| Q4 24 | — | 50.0% | ||
| Q3 24 | — | 47.4% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 45.4% |
| Q4 25 | 14.3% | 6.4% | ||
| Q3 25 | 61.8% | 15.2% | ||
| Q2 25 | 53.2% | -7.7% | ||
| Q1 25 | -70.7% | -37.1% | ||
| Q4 24 | 34.8% | 7.2% | ||
| Q3 24 | 28.0% | 1.5% | ||
| Q2 24 | 26.5% | 9.5% | ||
| Q1 24 | 14.7% | -2.2% |
| Q4 25 | -4.8% | 3.2% | ||
| Q3 25 | 32.8% | 16.5% | ||
| Q2 25 | 27.7% | -8.3% | ||
| Q1 25 | -90.9% | -35.5% | ||
| Q4 24 | 2.5% | 5.4% | ||
| Q3 24 | 4.0% | 0.8% | ||
| Q2 24 | -0.9% | 7.4% | ||
| Q1 24 | -5.6% | -6.2% |
| Q4 25 | $0.01 | $0.21 | ||
| Q3 25 | $0.23 | $0.93 | ||
| Q2 25 | $0.14 | $-0.37 | ||
| Q1 25 | $-0.23 | $-2.25 | ||
| Q4 24 | $0.03 | $0.34 | ||
| Q3 24 | $0.02 | $0.05 | ||
| Q2 24 | $-0.01 | $0.35 | ||
| Q1 24 | $-0.03 | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $1.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $53.4M |
| Total Assets | $396.9M | $246.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $1.1M | ||
| Q3 25 | $140.4M | $777.0K | ||
| Q2 25 | $92.9M | $2.6M | ||
| Q1 25 | $108.5M | $607.0K | ||
| Q4 24 | $88.6M | $892.0K | ||
| Q3 24 | $88.2M | $711.0K | ||
| Q2 24 | $105.5M | $739.0K | ||
| Q1 24 | $121.5M | $357.0K |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $53.4M | ||
| Q3 25 | $-264.2M | $49.3M | ||
| Q2 25 | $-308.2M | $37.2M | ||
| Q1 25 | $-334.1M | $41.8M | ||
| Q4 24 | $-301.3M | $57.1M | ||
| Q3 24 | $-311.3M | $52.4M | ||
| Q2 24 | $-321.7M | $51.7M | ||
| Q1 24 | $-330.5M | $47.2M |
| Q4 25 | $396.9M | $246.0M | ||
| Q3 25 | $396.1M | $239.0M | ||
| Q2 25 | $342.9M | $218.0M | ||
| Q1 25 | $327.2M | $222.7M | ||
| Q4 24 | $350.9M | $254.7M | ||
| Q3 24 | $389.5M | $253.6M | ||
| Q2 24 | $395.6M | $223.1M | ||
| Q1 24 | $438.8M | $225.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $-5.1M |
| Free Cash FlowOCF − Capex | $74.6M | $-5.7M |
| FCF MarginFCF / Revenue | 156.3% | -6.7% |
| Capex IntensityCapex / Revenue | 0.0% | 0.7% |
| Cash ConversionOCF / Net Profit | — | -1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $-5.1M | ||
| Q3 25 | $47.6M | $4.2M | ||
| Q2 25 | $-15.1M | $-11.8M | ||
| Q1 25 | $20.0M | $22.7M | ||
| Q4 24 | $15.2M | $6.4M | ||
| Q3 24 | $9.9M | $-3.2M | ||
| Q2 24 | $33.5M | $-3.9M | ||
| Q1 24 | $45.0M | $14.8M |
| Q4 25 | $74.6M | $-5.7M | ||
| Q3 25 | $47.6M | $2.1M | ||
| Q2 25 | $-15.1M | $-13.2M | ||
| Q1 25 | $19.9M | $21.2M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $9.9M | $-3.9M | ||
| Q2 24 | $33.4M | $-4.6M | ||
| Q1 24 | $44.9M | $14.2M |
| Q4 25 | 156.3% | -6.7% | ||
| Q3 25 | 39.0% | 2.9% | ||
| Q2 25 | -17.7% | -22.9% | ||
| Q1 25 | 48.4% | 26.5% | ||
| Q4 24 | — | 6.4% | ||
| Q3 24 | 10.8% | -5.2% | ||
| Q2 24 | 35.4% | -7.8% | ||
| Q1 24 | 60.0% | 18.9% |
| Q4 25 | 0.0% | 0.7% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.1% | 1.9% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.1% | 0.7% |
| Q4 25 | — | -1.86× | ||
| Q3 25 | 1.19× | 0.35× | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | 1.48× | ||
| Q3 24 | 2.71× | -5.61× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
VNCE
| Vince Wholesale | $52.0M | 61% |
| Vince Direct To Consumer | $33.1M | 39% |
